A Phase Ib Study of the Safety, Tolerability and Efficacy of LY2780301 in Combination With Gemcitabine

Clinical trial NCT02018874 · COMPLETED

Trial details

NCT number: NCT02018874
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors and Non-Hodgkin's Lymphoma

Start date: 2013-09-01
Primary completion: 2016-04-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.